PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
1873.HK vs. KGC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between 1873.HK and KGC is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.0

Performance

1873.HK vs. KGC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VIVA Biotech Holdings (1873.HK) and Kinross Gold Corporation (KGC). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%NovemberDecember2025FebruaryMarchApril
-68.93%
430.41%
1873.HK
KGC

Key characteristics

Sharpe Ratio

1873.HK:

1.85

KGC:

3.21

Sortino Ratio

1873.HK:

2.81

KGC:

3.39

Omega Ratio

1873.HK:

1.36

KGC:

1.46

Calmar Ratio

1873.HK:

1.79

KGC:

1.81

Martin Ratio

1873.HK:

6.73

KGC:

22.91

Ulcer Index

1873.HK:

25.66%

KGC:

6.00%

Daily Std Dev

1873.HK:

94.01%

KGC:

42.81%

Max Drawdown

1873.HK:

-96.27%

KGC:

-96.04%

Current Drawdown

1873.HK:

-87.86%

KGC:

-44.31%

Fundamentals

Market Cap

1873.HK:

HK$2.88B

KGC:

$18.21B

EPS

1873.HK:

HK$0.00

KGC:

$0.77

PE Ratio

1873.HK:

22.50

KGC:

19.22

PS Ratio

1873.HK:

1.45

KGC:

3.54

PB Ratio

1873.HK:

0.72

KGC:

2.65

Returns By Period

In the year-to-date period, 1873.HK achieves a 55.17% return, which is significantly lower than KGC's 60.09% return.


1873.HK

YTD

55.17%

1M

-25.00%

6M

51.69%

1Y

225.30%

5Y*

-21.88%

10Y*

N/A

KGC

YTD

60.09%

1M

21.71%

6M

40.29%

1Y

121.41%

5Y*

21.50%

10Y*

21.71%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

1873.HK vs. KGC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

1873.HK
The Risk-Adjusted Performance Rank of 1873.HK is 9393
Overall Rank
The Sharpe Ratio Rank of 1873.HK is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of 1873.HK is 9494
Sortino Ratio Rank
The Omega Ratio Rank of 1873.HK is 9292
Omega Ratio Rank
The Calmar Ratio Rank of 1873.HK is 9393
Calmar Ratio Rank
The Martin Ratio Rank of 1873.HK is 9191
Martin Ratio Rank

KGC
The Risk-Adjusted Performance Rank of KGC is 9797
Overall Rank
The Sharpe Ratio Rank of KGC is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of KGC is 9696
Sortino Ratio Rank
The Omega Ratio Rank of KGC is 9696
Omega Ratio Rank
The Calmar Ratio Rank of KGC is 9393
Calmar Ratio Rank
The Martin Ratio Rank of KGC is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

1873.HK vs. KGC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VIVA Biotech Holdings (1873.HK) and Kinross Gold Corporation (KGC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for 1873.HK, currently valued at 1.58, compared to the broader market-2.00-1.000.001.002.003.00
1873.HK: 1.58
KGC: 2.89
The chart of Sortino ratio for 1873.HK, currently valued at 2.57, compared to the broader market-6.00-4.00-2.000.002.004.00
1873.HK: 2.57
KGC: 3.19
The chart of Omega ratio for 1873.HK, currently valued at 1.34, compared to the broader market0.501.001.502.00
1873.HK: 1.34
KGC: 1.44
The chart of Calmar ratio for 1873.HK, currently valued at 1.50, compared to the broader market0.001.002.003.004.00
1873.HK: 1.50
KGC: 4.12
The chart of Martin ratio for 1873.HK, currently valued at 5.46, compared to the broader market-5.000.005.0010.0015.0020.00
1873.HK: 5.46
KGC: 20.16

The current 1873.HK Sharpe Ratio is 1.85, which is lower than the KGC Sharpe Ratio of 3.21. The chart below compares the historical Sharpe Ratios of 1873.HK and KGC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.58
2.89
1873.HK
KGC

Dividends

1873.HK vs. KGC - Dividend Comparison

1873.HK has not paid dividends to shareholders, while KGC's dividend yield for the trailing twelve months is around 0.81%.


TTM202420232022202120202019
1873.HK
VIVA Biotech Holdings
0.00%0.00%0.00%0.00%0.21%0.35%0.11%
KGC
Kinross Gold Corporation
0.81%1.29%1.98%2.93%2.07%0.82%0.00%

Drawdowns

1873.HK vs. KGC - Drawdown Comparison

The maximum 1873.HK drawdown since its inception was -96.27%, roughly equal to the maximum KGC drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for 1873.HK and KGC. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-87.86%
-1.53%
1873.HK
KGC

Volatility

1873.HK vs. KGC - Volatility Comparison

VIVA Biotech Holdings (1873.HK) has a higher volatility of 41.37% compared to Kinross Gold Corporation (KGC) at 14.04%. This indicates that 1873.HK's price experiences larger fluctuations and is considered to be riskier than KGC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
41.37%
14.04%
1873.HK
KGC

Financials

1873.HK vs. KGC - Financials Comparison

This section allows you to compare key financial metrics between VIVA Biotech Holdings and Kinross Gold Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. 1873.HK values in HKD, KGC values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab